Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination:A Case Report
10.9758/cpn.2022.20.4.777
- Author:
Pricilla Yani GUNAWAN
1
;
Pamela TIFFANI
;
Lilie LALISANG
Author Information
1. Department of Neurology, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
- Publication Type:Case Report
- From:Clinical Psychopharmacology and Neuroscience
2022;20(4):777-780
- CountryRepublic of Korea
- Language:English
-
Abstract:
After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.
